Q3FY25: Dr. Reddy’s to focus on continued CapEx investment, R&D and increasing capacity of existing portfolio – The Financial Express
Pharma major Dr. Reddy’s Laboratories on Thursday announced its consolidated net profit increased 2 per cent to Rs 1,413...
